ArticleJournal of ovarian research2016
HE4 promotes collateral resistance to cisplatin and paclitaxel in ovarian cancer cells.
J R Ribeiro et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
40 papers cite it
this paperpooled itcites it